story of the week
Mobocertinib in Platinum-Pretreated Patients With EGFRex20ins-Positive Metastatic NSCLC
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
JAMA Oncology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Treatment Outcomes and Safety of Mobocertinib in Platinum-Pretreated Patients With EGFR Exon 20 Insertion-Positive Metastatic Non-Small Cell Lung Cancer: A Phase 1/2 Open-label Nonrandomized Clinical Trial
JAMA Oncol 2021 Oct 14;[EPub Ahead of Print], C Zhou, SS Ramalingam, TM Kim, SW Kim, JC Yang, GJ Riely, T Mekhail, D Nguyen, MR Garcia Campelo, E Felip, S Vincent, S Jin, C Griffin, V Bunn, J Lin, HM Lin, M Mehta, PA JänneFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.